SecBot SecBot
SECBOTREPLAY Home › Report › SYRE

SYRE · Two key executives at Spyre Therapeutics, the CFO and CMO, sold a…

Spyre Therapeutics, Inc. · CLUSTER filed Mar 31, 2026 at 20:00 ET

At the news

BEARISHIMPACT 6/10

CLUSTER filed Mar 31, 2026 at 20:00 ET

Two key executives at Spyre Therapeutics, the CFO and CMO, sold a combined $703K in open-market transactions on April 1, 2026, following derivative exercises. The sales represent a modest but notable insider selling cluster involving C-suite leadership.

  • CFO Burrows Scott L sold 6,200 shares for $305,102 at $49.21 per share.
  • CMO Sloan Sheldon sold 7,958 shares for $397,900 at $50.00 per share.
  • Both executives also exercised in-the-money derivatives prior to selling, with no additional open-market purchases.
  • Total open-market sale value: $703K, representing ~0.019% of $3.7B market cap, modest in size but significant due to C-suite participation.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access